Abstract 3901: Identification of genomic pathways associated with resistance of NSCLC to immunotherapies containing granzyme B
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-3901
Abstract: Immuno-oncologic (IO) approaches have completely transformed lung cancer treatment. Unfortunately, most patients with NSCLC develop primary resistance during IO and less than 20% achieve partial or complete response. Understanding the pathways to resistance is a… read more here.
Keywords: cell; research; resistance; grb it4 ... See more keywords